Kathrin Thedieck

Prof. Dr. Kathrin Thedieck is a Professor of Metabolism, Senescence, and Autophagy at the University of Duisburg-Essen's Faculty of Medicine, affiliated with the Research Center One Health Ruhr. Her research focuses on metabolic signaling networks, particularly the mTOR pathway, and their roles in cancer, rare diseases, and aging. She leads the Lab for Metabolic Signaling, investigating stress granules' influence on mTOR regulation and their implications for breast cancer and other tumors. Her work integrates proteomics, metabolomics, and systems biology. Notably, she holds an ERC Advanced Grant and has received awards for her studies on tuberous sclerosis and therapeutic strategies.

Education: Studied Biology (University of Münster, 1996-1998) and Biotechnology (Ecole Supérieure de Biotechnologie Strasbourg, 1999-2001). PhD from Helmholtz Center for Infection Research (2005). Postdoc at University of Basel (2006) with Michael N. Hall. Previous roles include group leader at University of Freiburg (2008-2013), Associate Professor at Universities of Groningen and Oldenburg (2013-2019), and Professor/Institute Head at University of Innsbruck (2019-2024).

Research: Explores mTOR's role in metabolism, cancer, and rare diseases. Projects like ERC-funded 'BEYOND STRESS' study stress granules' regulatory effects on mTOR. Collaborates across disciplines using advanced omics technologies. Awards include Klüh Foundation Prize (2024) and German Tuberous Sclerosis Foundation Research Award (2017).

Labs & Grants: Lab for Metabolic Signaling (https://metabolic-signaling.eu/). ERC AdG grant (€2.5M). Active in University Alliance Ruhr initiatives.